(Q42210892)

English

Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka

scientific article published on 18 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Japanese encephalitis virus

0 references

1 reference

based on heuristic

inferred from title

attenuated vaccine

1 reference

based on heuristic

inferred from title

Japanese encephalitis

1 reference

based on heuristic

inferred from title

measles vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kathleen Neuzil

8

object named as

Kathleen M Neuzil

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

author name string

Pushpa Ranjan Wijesinghe

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

M R Nihal Abeysinghe

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sutee Yoksan

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Yafu Yao

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Benli Zhou

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Lei Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Mansour Yaich

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

John C Victor

9

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

language of work or name

0 references

publication date

18 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

4751-4757

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Corrigendum to “Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants” [Vaccine 26 (2008) 2234–2241]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Japanese encephalitis: a Chinese solution?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.036

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.06.036

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42210892&oldid=1936008757"